drugset / Trial / NCT06631365

PrEPsmart 2-1-1 Pilot

NCT06631365

RandomizedParallel-groupOpen-labelPrevention

Summary

This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly innovative tool to support men who have sex with men (MSM) using on-demand PrEP ready for testing in a larger efficacy trial

Timeline

Start
2023-10-02
Primary completion
2025-01-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Background Tenofovir disoproxil fumarate Small molecule
Background emtricitabine Other / unclassified